Khoom Taw Qhia

Tom ntej: Octreotide CAS: 79517-01-4yog ib qho hluavtaws cyclic octapeptide, ib qho analogue ntawm ntuj somatostatin nrog rau cov tshuaj siv tshuaj ntev ntev. Nws khi xaiv rau somatostatin receptors, inhibiting qhov tso tawm ntawm kev loj hlob hormone, insulin, glucagon, thiab ntau yam kab mob plab peptides. Vim nws qhov ruaj khov thiab txuas ntxiv ib nrab- lub neej, Octreotide tau dav siv hauv kev kho mob acromegaly, qog nqaij hlav carcinoid, vasoactive plab hnyuv peptide (VIP) qog, thiab plab hnyuv los ntshav.

Khoom Parameter (Specification)

Parameter	Kev piav qhia
Khoom npe	Octreotide
CAS Nr.	79517-01-4
Molecular Formula	C₄₉H₆₆N₁₀O₁₀S₂
Molecular Luj	1019.25 g / mol
Purity	Ntau dua lossis sib npaug li 98% (HPLC)
Qhov tshwm sim	Dawb rau tawm -dawb hmoov
Solubility	Soluble hauv dej thiab acetic acid
Cia	Khaws ntawm -20 degree, tiv thaiv los ntawm lub teeb thiab noo noo
Qib	Pharmaceutical qib
Txee lub neej	2 xyoos thaum khaws cia zoo

Khoom Feature thiab Daim Ntawv Thov

Synthetic ntev - ua yeeb yam somatostatin analogue nrog muaj zog receptor affinity.
Inhibits ntau secretion ntawm kev loj hlob hormone thiab plab hnyuv peptides.
Siv tshuaj kho mob los kho acromegaly, carcinoid syndrome, thiab VIP- zais cov qog.
Kuj tseem muaj txiaj ntsig zoo hauv kev tswj cov ntshav variceal thiab postoperative pancreatic fistula.
Haum rau kev txhaj tshuaj formulations thiab daim ntawv thov kev tshawb fawb peptide.

Paub meej ntau lawm

Octreotide yog synthesized los ntawm cov khoom siab tshaj -theem peptide synthesis (SPPS) thiab purified los ntawm ntau cov kauj ruam chromatographic. Txhua pawg tsim khoom raug sim rau tus kheej, purity, thiab potency siv HPLC, LC-MS, thiab NMR. Kev tsim khoom nruj me ntsis ua raws li GMP thiab ISO 9001 cov qauv kom ntseeg tau tias cov tshuaj zoo ib yam - qib zoo.

Cov khoom tsim nyog

Peb cov Octreotide yog tsim nyob rau hauv GMP-cov chaw muaj ntawv pov thawj siv high-purity amino acid raw cov ntaub ntawv. Cov txheej txheem ua raws li cov qauv tshuaj pharmacopoeial thoob ntiaj teb. Cov ntaub ntawv tshuaj ntsuam xyuas tag nrho- suav nrog COA, MSDS, thiab TDS- muaj nyob rau ntawm qhov kev thov. Txhua batch yog validated rau purity, stability, thiab bioactivity ua ntej xa zaub mov.

Delivery, Shipping thiab Pab

Ntim

1g, 10g, lossis customized kom muaj nuj nqis.

Lub Sijhawm Lead

3-5 hnub ua haujlwm tom qab tau txais kev pom zoo.

Kev xa khoom

Xa los ntawm FedEx, DHL, lossis cov neeg siv khoom nyiam nyob rau hauv qhov ntsuas kub.

Txhawb nqa

Cov ntaub ntawv txuj ci, COA, thiab tom qab - kev muag khoom yog muab los ua kom cov neeg siv khoom txaus siab.

FAQ

Q1: Dab tsi yog cov lus qhia tseem ceeb rau Octreotide?

A1: Octreotide feem ntau yog siv los kho acromegaly, carcinoid qog, thiab VIP- zais qog los ntawm kev txo qis cov tshuaj hormones ntau dhau.

Q2: Yuav khaws Octreotide li cas?

A2: Khaws ntawm -20 degree, tiv thaiv lub teeb thiab noo noo. Khaws kaw thiab qhuav kom ruaj khov siab tshaj plaws.

Q3: Puas yog Octreotide muaj nyob rau hauv GMP zoo?

A3: Yog lawm, peb cov Octreotide yog tsim nyob rau hauv GMP-cov ntaub ntawv pov thawj thiab tuaj nrog ua tiav COA thiab MSDS cov ntaub ntawv.

Xov xwm tshiab

Peb cov khoom lag luam peptide suav nrog ntau yam kev kho mob thiab kev tshawb fawb- qib analogues xws li Octreotide, Lanreotide, thiab Pasireotide. Los ntawm kev sib txuas cov thev naus laus zis peptide siab tshaj plaws nrog kev tswj hwm GMP nruj, peb txuas ntxiv xa cov qib siab - zoo peptide APIs txhawb kev tshawb fawb endocrinology thiab oncology thoob ntiaj teb.

Cim npe nrov: Tuam Tshoj octreotide (cas: 79517-01-4), Tuam Tshoj octreotide (cas: 79517-01-4) manufacturers, lwm tus neeg